However, successive works which adopted different experimental approaches to measure NF-κB activity, showed that even the chronic phase of CML is associated with an increased NF-κB activation [72] when compared to normal bone marrow samples, suggesting a functional heterogeneity. Here, NFKB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.